FRACTYL HEALTH INC (GUTS) Stock Fundamental Analysis

NASDAQ:GUTS • US35168W1036

0.506 USD
+0.02 (+4.55%)
At close: Feb 25, 2026
0.5109 USD
+0 (+0.97%)
Pre-Market: 2/26/2026, 8:14:14 AM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to GUTS. GUTS was compared to 185 industry peers in the Health Care Equipment & Supplies industry. GUTS has a bad profitability rating. Also its financial health evaluation is rather negative. GUTS has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • In the past year GUTS has reported negative net income.
  • GUTS had a negative operating cash flow in the past year.
  • In the past 5 years GUTS always reported negative net income.
  • In the past 5 years GUTS always reported negative operating cash flow.
GUTS Yearly Net Income VS EBIT VS OCF VS FCFGUTS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -20M -40M -60M -80M

1.2 Ratios

  • GUTS has a worse Return On Assets (-106.94%) than 80.00% of its industry peers.
Industry RankSector Rank
ROA -106.94%
ROE N/A
ROIC N/A
ROA(3y)-97.75%
ROA(5y)-92.56%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
GUTS Yearly ROA, ROE, ROICGUTS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 200 -200 -400

1.3 Margins

  • GUTS has a Gross Margin of 100.00%. This is amongst the best in the industry. GUTS outperforms 100.00% of its industry peers.
  • GUTS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 100%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
GUTS Yearly Profit, Operating, Gross MarginsGUTS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 -20K -40K -60K -80K -100K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. Health

2.1 Basic Checks

  • GUTS does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • GUTS has more shares outstanding than it did 1 year ago.
  • GUTS has more shares outstanding than it did 5 years ago.
  • GUTS has a better debt/assets ratio than last year.
GUTS Yearly Shares OutstandingGUTS Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
GUTS Yearly Total Debt VS Total AssetsGUTS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

  • GUTS has an Altman-Z score of -8.09. This is a bad value and indicates that GUTS is not financially healthy and even has some risk of bankruptcy.
  • The Altman-Z score of GUTS (-8.09) is worse than 73.51% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -8.09
ROIC/WACCN/A
WACC10.06%
GUTS Yearly LT Debt VS Equity VS FCFGUTS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 50M -50M

2.3 Liquidity

  • GUTS has a Current Ratio of 4.27. This indicates that GUTS is financially healthy and has no problem in meeting its short term obligations.
  • The Current ratio of GUTS (4.27) is better than 71.35% of its industry peers.
  • A Quick Ratio of 4.27 indicates that GUTS has no problem at all paying its short term obligations.
  • GUTS's Quick ratio of 4.27 is fine compared to the rest of the industry. GUTS outperforms 76.76% of its industry peers.
Industry RankSector Rank
Current Ratio 4.27
Quick Ratio 4.27
GUTS Yearly Current Assets VS Current LiabilitesGUTS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. Growth

3.1 Past

  • The earnings per share for GUTS have decreased strongly by -59.13% in the last year.
  • The Revenue for GUTS has decreased by -96.91% in the past year. This is quite bad
EPS 1Y (TTM)-59.13%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-47.92%
Revenue 1Y (TTM)-96.91%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-100%

3.2 Future

  • The Earnings Per Share is expected to grow by 15.23% on average over the next years. This is quite good.
  • GUTS is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 450.37% yearly.
EPS Next Y-7.2%
EPS Next 2Y24.1%
EPS Next 3Y16.18%
EPS Next 5Y15.23%
Revenue Next Year-100%
Revenue Next 2Y-41.42%
Revenue Next 3Y664.32%
Revenue Next 5Y450.37%

3.3 Evolution

GUTS Yearly Revenue VS EstimatesGUTS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2027 2028 2029 2030 100M 200M 300M 400M
GUTS Yearly EPS VS EstimatesGUTS Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 2028 2029 2030 0 -10 -20 -30

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • GUTS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year GUTS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
GUTS Price Earnings VS Forward Price EarningsGUTS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
GUTS Per share dataGUTS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.5 -1 -1.5 -2

4.3 Compensation for Growth

  • A more expensive valuation may be justified as GUTS's earnings are expected to grow with 16.18% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y24.1%
EPS Next 3Y16.18%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for GUTS!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

FRACTYL HEALTH INC

NASDAQ:GUTS (2/25/2026, 8:17:43 PM)

Premarket: 0.5109 +0 (+0.97%)

0.506

+0.02 (+4.55%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-12
Earnings (Next)03-03
Inst Owners71.87%
Inst Owner Change15.48%
Ins Owners1.53%
Ins Owner Change0.09%
Market Cap77.61M
Revenue(TTM)3.00K
Net Income(TTM)-122.20M
Analysts83.64
Price Target5.34 (955.34%)
Short Float %9.85%
Short Ratio2.2
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-87.75%
Min EPS beat(2)-120.28%
Max EPS beat(2)-55.23%
EPS beat(4)0
Avg EPS beat(4)-48.37%
Min EPS beat(4)-120.28%
Max EPS beat(4)-0.78%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-25.57%
PT rev (3m)-25.57%
EPS NQ rev (1m)0%
EPS NQ rev (3m)7.22%
EPS NY rev (1m)1.35%
EPS NY rev (3m)-8.06%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 25868.41
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-2.29
EYN/A
EPS(NY)-0.7
Fwd EYN/A
FCF(TTM)-0.57
FCFYN/A
OCF(TTM)-0.56
OCFYN/A
SpS0
BVpS-0.02
TBVpS-0.02
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -106.94%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 100%
FCFM N/A
ROA(3y)-97.75%
ROA(5y)-92.56%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 73.35%
Cap/Sales 26233.3%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.27
Quick Ratio 4.27
Altman-Z -8.09
F-Score2
WACC10.06%
ROIC/WACCN/A
Cap/Depr(3y)132.87%
Cap/Depr(5y)81.29%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-59.13%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-47.92%
EPS Next Y-7.2%
EPS Next 2Y24.1%
EPS Next 3Y16.18%
EPS Next 5Y15.23%
Revenue 1Y (TTM)-96.91%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-100%
Revenue Next Year-100%
Revenue Next 2Y-41.42%
Revenue Next 3Y664.32%
Revenue Next 5Y450.37%
EBIT growth 1Y-21.45%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-10.49%
EBIT Next 3Y-4.97%
EBIT Next 5Y23.95%
FCF growth 1Y-93%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-92.21%
OCF growth 3YN/A
OCF growth 5YN/A

FRACTYL HEALTH INC / GUTS FAQ

What is the fundamental rating for GUTS stock?

ChartMill assigns a fundamental rating of 2 / 10 to GUTS.


What is the valuation status for GUTS stock?

ChartMill assigns a valuation rating of 0 / 10 to FRACTYL HEALTH INC (GUTS). This can be considered as Overvalued.


What is the profitability of GUTS stock?

FRACTYL HEALTH INC (GUTS) has a profitability rating of 1 / 10.


What is the financial health of FRACTYL HEALTH INC (GUTS) stock?

The financial health rating of FRACTYL HEALTH INC (GUTS) is 3 / 10.


What is the earnings growth outlook for FRACTYL HEALTH INC?

The Earnings per Share (EPS) of FRACTYL HEALTH INC (GUTS) is expected to decline by -7.2% in the next year.